tiprankstipranks
Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
US Market

Avenue Therapeutics (ATXI) Stock News & Sentiment

331 Followers
Avenue Therapeutics Licenses ATX-04 for Pompe Disease
Premium
Company Announcements
Avenue Therapeutics Licenses ATX-04 for Pompe Disease
2M ago
Avenue Therapeutics shareholders elect directors, ratify KPMG auditor
Premium
Company Announcements
Avenue Therapeutics shareholders elect directors, ratify KPMG auditor
3M ago
Avenue Therapeutics Announces 2025 Annual Meeting Date
Premium
Company Announcements
Avenue Therapeutics Announces 2025 Annual Meeting Date
5M ago
Avenue Therapeutics Reports Improved Financials Amid Challenges
Premium
Company Announcements
Avenue Therapeutics Reports Improved Financials Amid Challenges
5M ago
Avenue Therapeutics Sells Baergic Bio to Axsome
Premium
Company Announcements
Avenue Therapeutics Sells Baergic Bio to Axsome
5M ago
Avenue Therapeutics Reports Positive Earnings Amid Challenges
Premium
Company Announcements
Avenue Therapeutics Reports Positive Earnings Amid Challenges
8M ago
Avenue Therapeutics Ends License Agreement with AnnJi
Premium
Company Announcements
Avenue Therapeutics Ends License Agreement with AnnJi
12M ago
More ATXI News >

ATXI News on the Web

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATXI’s Media Buzz Sentiment?
Currently, no data Available
What is ATXI’s weekly average amount of articles?
Currently, no data Available
What is ATXI’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
STAAStaar Surgical
ALLOAllogene Therapeutics
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week